News
Sheffield team top UK recruiter in IPF trial
Dr Stephen Bianchi and the clinical Research Facility team were the top UK recruiting site for INSTAGE, a clinical trial for people with idiopathic pulmonary fibrosis. @CRFSheffield supported #clinicaltrial in #lungdisease. @SheffieldHosp is the ...
Read More “REPLACE Trial of Riociguat for Pulmonary Arterial Hypertension
Dr Robin Condliffe and the Royal Hallamshire Clinical Research Facility are starting a trial of Riociguat, a drug for people with Pulmonary Arterial Hypertension (PAH). The trial is sponsored by Bayer PLC. Current PAH treatments include phosphodie...
Read More STH success in national research league table
Sheffield Teaching Hospitals has been named in the top ten research active NHS Trusts in the NIHR Research Activity League Table 2016-2017. Last year 11,490 patients took part in clinical research studies in STH, a 34% increase from the previ...
Read More
CF Health Hub Data Observatory
A Quality Improvement project and Trials within Cohort platform for Cystic Fibrosis: The Data Observatory project aims to build on the work of the CFHealthHub and the ACTIF Programme Grant led by a Sheffield research team (Chief Investigators Dr ...
Read More Cystic Fibrosis Annual Newlstter
The Sheffield Adult Cytic Fibrosis Centre has published its annual newsletter: down load it here: http://www.lungsheffield.org/clinical-services/newsletter
Read More
Patient guide to getting involve in clinical research
The Sheffield Pulmonary Vascular Disease Unit, in collaboration with the UK Pulmonary Hypertension Association, has produced a guide for patients about getting involved in research, and about the pulmonary vascular research programme in Sheffield....
Read More Trial for patients with "unclassifiable" pulmonary fibrosis
Dr Stephen Bianchi and a research team from the Clinical Research Facility, Pharmacy, Labs and Respiratory Function Unit, are starting a new clinical trial for patients who have a type of pulmonary fibrosis which, for reasons unknown, cannot ...
Read More New COPD Trial: “SOPHOS”
Metered Dose Inhalers (MDIs) are the most common type of device to deliver inhaled drugs to patients with Chronic Obstructive Pulmonary Disease. Yet many COPD treatments, particularly dual and triple combinations, have proven difficult to develop ...
Read More New Mesothelioma trial: “TARGET”
Dr Leon Lewis and Dr Duneesha De Fonseka are participating in a trial for patients who are being investigated for suspected mesothelioma. The principal research question is whether a PET-CT-targeted biopsy is more likely to give a diagnosis than a...
Read More
1st UK patients in clinical trial for Idiopathic Lung Fibrosis
A study team from Sheffield Teaching Hospitals Respiratory Medicine have recruited the 1st and 2nd UK patients to take part in a clinical trial of a new type of treatment for the condition idiopathic lung fibrosis (IPF). Consultant Dr Stephen Bia...
Read More